TickerFacts.

Company research / RMD

ResMed Inc (RMD)

Also trades as RSMDF. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

Build a valuation ↗↓ Download CSV

SEC name RESMED INC · CIK 0000943819 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, ResMed Inc reported revenue of $5.65B. Revenue grew 9.9% from the prior annual period.

Key ratios (year ended 2026-06-30)

61.1%
Gross margin
33.4%
Operating margin
26.9%
Net margin
23.1%
Return on year-end equity
9.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-08

Headquarters locality: San Diego · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$5.65B$5.15B$4.69B$4.22B$3.58B$3.20B$2.96B$2.61B$2.34B$2.07B
Cost of Revenue$2.20B$2.09B$2.03B$1.87B$1.55B$1.36B$1.24B$1.11B$1.01B$864.99M
Gross Profit$3.45B$3.05B$2.66B$2.36B$2.02B$1.84B$1.72B$1.49B$1.33B$1.20B
R&D Expense$378.29M$331.28M$307.52M$287.64M$253.57M$225.28M$201.95M$180.65M$155.15M$144.47M
Operating Income$1.89B$1.69B$1.32B$1.13B$1.00B$903.68M$809.66M$579.26M$541.83M$425.80M
Depreciation & Amortization$201.34M$198.47M$176.87M$165.16M$159.61M$156.76M$154.85M$150.79M$119.96M$112.16M
EBITDA$2.09B$1.88B$1.50B$1.30B$1.16B$1.06B$964.51M$730.06M$661.79M$537.96M
Net Income$1.52B$1.40B$1.02B$897.56M$779.44M$474.50M$621.67M$404.59M$315.59M$342.28M
EPS (Diluted)$10.43$9.51$6.92$6.09$5.30$3.24$4.27$2.80$2.19$2.40
Total Assets$8.97B$8.17B$6.87B$6.75B$5.10B$4.73B$4.59B$4.11B$3.06B$3.47B
Total Liabilities$2.38B$2.21B$2.01B$2.62B$1.74B$1.84B$2.09B$2.04B$1.00B$1.51B
Long-Term Debt$399.42M$658.39M$697.31M$1.43B$765.33M$643.35M$1.16B$1.26B$269.99M$1.08B
Shareholders' Equity$6.59B$5.97B$4.86B$4.13B$3.36B$2.89B$2.50B$2.07B$2.06B$1.96B
Cash & Equivalents$1.47B$1.21B$238.36M$227.89M$273.71M$295.28M$463.16M$147.13M$188.70M$821.93M
Operating Cash Flow$1.81B$1.75B$1.40B$693.30M$351.15M$736.72M$802.25M$459.05M$505.03M$414.05M
Capital Expenditures$156.28M$89.86M$99.46M$119.67M$134.84M$102.71M$95.33M$68.71M$62.58M$62.22M
Free Cash Flow$1.65B$1.66B$1.30B$573.63M$216.31M$634.01M$706.92M$390.34M$442.44M$351.83M
Share Repurchases$700.04M$300.02M$150.01M$0$0n/an/a$22.84M$53.80Mn/a
Dividends Paid$349.66M$310.88M$282.32M$258.28M$245.34M$226.71M$225.09M$211.71M$199.50M$186.35M
Shares Outstanding144.24M146.39M146.90M147.06M146.41M145.65M144.89M143.65M142.68M142.17M
Dividends Per Share$2.40$2.12$1.92$1.76$1.68$1.56$1.56$1.48$1.40$1.32
Weighted Average Diluted Shares146.05M147.34M147.55M147.46M147.04M146.45M145.65M144.48M143.99M142.45M
EPS (Basic)$10.47$9.55$6.94$6.12$5.34$3.27$4.31$2.83$2.21$2.42

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView